Literature DB >> 5080151

Effects of apomorphine on exploration.

S G Carlsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5080151     DOI: 10.1016/0031-9384(72)90282-x

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


× No keyword cloud information.
  7 in total

1.  Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2017-07-20       Impact factor: 2.643

2.  Methylphenidate attenuates rats' preference for a novel spatial stimulus introduced into a familiar environment: assessment using a force-plate actometer.

Authors:  Stephen C Fowler; Troy J Zarcone; Beth Levant
Journal:  J Neurosci Methods       Date:  2010-03-25       Impact factor: 2.390

3.  Differences in methylphenidate dose response between periadolescent and adult rats in the familiar arena-novel alcove task.

Authors:  Beth Levant; Troy J Zarcone; Paul F Davis; Marlies K Ozias; Stephen C Fowler
Journal:  J Pharmacol Exp Ther       Date:  2010-12-28       Impact factor: 4.030

4.  Impairment of responses to novelty by apomorphine and its antagonism by neuroleptics in mice.

Authors:  R Misslin; P Ropartz; L Jung
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Influence of catecholamines on dexamphetamine-induced changes in locomotor activity.

Authors:  S L Handley; K V Thomas
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

6.  [Aggressive behaviour induced by apomorphine: relations with some elements of the behavioural profile and with the sensitivity to apomorphine (author's transl)].

Authors:  B Senault
Journal:  Psychopharmacology (Berl)       Date:  1976-07-09       Impact factor: 4.530

7.  Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.

Authors:  L M Moran; R M Booze; K M Webb; C F Mactutus
Journal:  Exp Neurol       Date:  2012-10-11       Impact factor: 5.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.